Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory.
about
Stable isotope-resolved metabolomics and applications for drug developmentIntraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancerEvaluation of the performance of a tandem mass spectral library with mass spectral data extracted from literature.Steroid hormone analysis in diagnosis and treatment of DSD: position paper of EU COST Action BM 1303 'DSDnet'.Development and validation of an LC-MS/MS assay for the quantification of the trans-methylation pathway intermediates S-adenosylmethionine and S-adenosylhomocysteine in human plasmaValidation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA.Turbulent flow chromatography in bioanalysis: a review.LC-MS/MS in the Clinical Laboratory - Where to From Here?Comparative triplex tandem mass spectrometry assays of lysosomal enzyme activities in dried blood spots using fast liquid chromatography: application to newborn screening of Pompe, Fabry, and Hurler diseases.A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma.Improved identification of multiple drugs of abuse and relative metabolites in urine samples using liquid chromatography/triple quadrupole mass spectrometry coupled with a library search.A validated LC-MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid.Determination of rifampicin in human plasma by high-performance liquid chromatography coupled with ultraviolet detection after automatized solid-liquid extraction.Evaluation of protein quantification using standard peptides containing single conservative amino acid replacementsConventional liquid chromatography/triple quadrupole mass spectrometry based metabolite identification and semi-quantitative estimation approach in the investigation of in vitro dabigatran etexilate metabolism.Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixturesQuantitative UPLC-MS/MS analysis of the gut microbial co-metabolites phenylacetylglutamine, 4-cresyl sulphate and hippurate in human urine: INTERMAP Study.Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies.Development and validation of LC-MS/MS method for determination of very long acyl chain (C22:0 and C24:0) ceramides in human plasmaMultisteroid LC-MS/MS assay for glucocorticoids and androgens, and its application in Addison's diseaseDetermination of 7α-OH cholesterol by LC-MS/MS: Application in assessing the activity of CYP7A1 in cholestatic minipigs.Immunoaffinity capillary electrophoresis: a new versatile tool for determining protein biomarkers in inflammatory processes.Challenges and benefits of endogenous steroid analysis by LC-MS/MS.Current applications of high-resolution mass spectrometry in drug metabolism studies.Aspects of matrix effects in applications of liquid chromatography-mass spectrometry to forensic and clinical toxicology--a review.Usage and limitations of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical routine laboratories.The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.Vitamin D and metabolites measurement by tandem mass spectrometry.Revisiting hyper- and hypo-androgenism by tandem mass spectrometry.Mass spectrometry and NMR spectroscopy: modern high-end detectors for high resolution separation techniques--state of the art in natural product HPLC-MS, HPLC-NMR, and CE-MS hyphenations.Oral fluid for the detection of drugs of abuse using immunoassay and LC-MS/MS.Recent advances in LC-MS/MS analysis of Δ(9)-tetrahydrocannabinol and its metabolites in biological matrices.Recent advances in MS methods for nicotine and metabolite analysis in human matrices: clinical perspectives.A validated LC-MS/MS method for cellular thyroid hormone metabolism: Uptake and turnover of mono-iodinated thyroid hormone metabolites by PCCL3 thyrocytes.Advances in bioanalytical techniques to measure steroid hormones in serum.Deployment-Associated Exposure Surveillance With High-Resolution Metabolomics.First UHPLC-MS/MS method coupled with automated online SPE for quantification both of tacrolimus and everolimus in peripheral blood mononuclear cells and its application on samples from co-treated pediatric patients.Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect.A novel stable isotope labelling assisted workflow for improved untargeted LC-HRMS based metabolomics research.Study of Isobaric Interference in Quantification of Citrulline by Parallel Fragmentation Monitoring.
P2860
Q24629149-6B9D74E4-B6C9-489E-96C9-4A30D7A228F5Q27005840-58869A52-4F91-4EF1-BA8E-E94E0B29113BQ33452095-61274C72-CB49-401E-9E9A-A55807D93211Q33659973-B7E55111-3CF7-4EF3-B1D4-FE3F8DD7F5F4Q33662536-E48CEB86-130A-4233-AAF7-E0045A658580Q34124314-179B7F45-BF41-4C10-AE37-78E07519BCDCQ34317104-84DA3B98-46CA-4260-A67A-82F78CE880EFQ34640830-FA53C9D5-36A7-41F1-8A34-930131F577C4Q35046409-20012FA1-7B2C-4091-AE26-AA21EAF75CF2Q35067272-DE5EA9FB-DD96-4D4F-8F24-3534DD8039B0Q35231662-7EF17643-A776-4F02-B03E-A367F5DDEFD1Q35642924-75EBAC31-C6D0-409C-A755-E284807B01FEQ36046376-B5DE380D-02BD-4162-BEFC-B4956D909D91Q36301398-DEA81BC9-DA35-451D-9CB7-6014AF738AFDQ36553553-AE322A58-0C57-4880-B328-90F9E52BD693Q36881534-13193132-24E7-4F3F-A6F8-6A6B239C33EAQ37087386-C546315A-4AE0-43B2-9747-7BC0A5998A66Q37142875-A8057B86-84A7-47A8-BEC3-D5FE3C2C8854Q37155265-380B08D6-5079-4AFD-9E55-2FC2980E253EQ37354259-CB2CF88B-A90D-480F-A136-C212EC27B954Q37711000-36F157E5-C458-4A78-9925-56BBF5710861Q37885859-B1A188F9-5D62-44FC-B86F-1472D9009359Q37961970-1EACD0C9-EE5E-4EF4-AC6D-03EEAF8C7465Q37986333-1F915FFC-8B87-472C-A2F0-292A0AD1E8D3Q38006891-3D9D7336-C399-47BF-B413-617831F6E5DEQ38058053-419FDEF3-2213-4A47-A692-E06C3F4CE2EAQ38089640-0729D75D-2B44-414D-A04F-F5370C279C6BQ38094123-14ACE6E8-BE90-442F-AA52-F67D8C560C7BQ38101855-B5197F9A-DD49-45E4-ACD4-B99BB7B41DB5Q38112324-6A166E61-3A85-4E44-98F0-548E3219D20FQ38116571-763047A5-9AEB-4F19-9EC6-ECA4E452ACF7Q38158190-67BAACAB-D411-4B5E-8A3C-3A90B936F503Q38261595-CDB9A308-BC84-446A-8D16-C9320AC148D3Q38610096-D4881C51-83D1-41D3-BC4C-CE4CBB13468FQ38842710-A7660B9C-8D8B-41CC-88DB-89F3A534FDD3Q38921721-2719655E-7EAF-4A76-9598-894E55C3118BQ39015263-62E91E8A-38F0-4811-A9F0-9454FE793D00Q40122652-F0FEB7D3-67B4-41D4-8B7D-50FAA946AE9FQ41899330-5D105475-2558-4657-8D5B-BFAA7ED0C1C2Q42604161-07D4ABFD-84FA-4BFC-8D72-85CECD045952
P2860
Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pitfalls associated with the u ...... ry in the clinical laboratory.
@ast
Pitfalls associated with the u ...... ry in the clinical laboratory.
@en
type
label
Pitfalls associated with the u ...... ry in the clinical laboratory.
@ast
Pitfalls associated with the u ...... ry in the clinical laboratory.
@en
prefLabel
Pitfalls associated with the u ...... ry in the clinical laboratory.
@ast
Pitfalls associated with the u ...... ry in the clinical laboratory.
@en
P1433
P1476
Pitfalls associated with the u ...... ry in the clinical laboratory.
@en
P2093
Michael Vogeser
P304
P356
10.1373/CLINCHEM.2009.138602
P407
P577
2010-05-28T00:00:00Z